Myxobacteria:: proficient producers of novel natural products with various biological activities -: past and future biotechnological aspects with the focus on the genus Sorangium

被引:246
作者
Gerth, K
Pradella, S
Perlova, O
Beyer, S
Müller, R
机构
[1] GBF, D-38124 Braunschweig, Germany
[2] Tech Univ, Inst Pharmazeut Biol, D-38106 Braunschweig, Germany
关键词
Myxobacteria; Sorangium; epothilone; soraphen; myxovirescin; regulation; genome sequence; So ce56; secondary metabolism;
D O I
10.1016/j.jbiotec.2003.07.015
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Myxobacteria are gram-negative bacteria which are most noted for their ability to form fruiting bodies upon starvation. Within the last two decades, they increasingly gained attention as producers of natural products with biological activity. Here, recent and future biotechnological research on certain key myxobacteria and on their ability to produce natural products is reviewed with the focus on the production of myxovirescin, soraphen and epothilone. Aspects of product improvement and yield as well as statistics regarding secondary metabolite formation are discussed. Future research will deal with the exploitation of the biosynthetic potential of the myxobacteria, for example via the isolation of new myxobacterial species with different physiological properties. Additionally, the genetic potential of myxobacteria to form natural products can be exploited by the identification and activation of biosynthetic gene clusters. These can be found frequently within their genomes, which is shown by the analysis of the unfinished genomes of Myxococcus xanthus and Sorangium cellulosum. The current status of the S. cellulosum functional genome project with model strain So ce56 is discussed. (C) 2003 Elsevier B.X. All rights reserved.
引用
收藏
页码:233 / 253
页数:21
相关论文
共 91 条
[51]  
KATO HIROSHI, 1955, ECOL REV, V14, P25
[52]   On the mechanism of action of the myxobacterial fungicide ambruticin [J].
Knauth, P ;
Reichenbach, H .
JOURNAL OF ANTIBIOTICS, 2000, 53 (10) :1182-1190
[53]  
KOHL W, 1983, J GEN MICROBIOL, V129, P1629
[54]   Ratjadones inhibit nuclear export by blocking CRM1/exportin 1 [J].
Köster, M ;
Lykke-Andersen, S ;
Elnakady, YA ;
Gerth, K ;
Washausen, P ;
Höfle, G ;
Sasse, F ;
Kjems, J ;
Hauser, H .
EXPERIMENTAL CELL RESEARCH, 2003, 286 (02) :321-331
[55]   CHONDRAMIDES-A-SIMILAR-TO-D, NEW ANTIFUNGAL AND CYTOSTATIC DEPSIPEPTIDES FROM CHONDROMYCES-CROCATUS (MYXOBACTERIA) - PRODUCTION, PHYSICOCHEMICAL AND BIOLOGICAL PROPERTIES [J].
KUNZE, B ;
JANSEN, R ;
SASSE, F ;
HOFLE, G ;
REICHENBACH, H .
JOURNAL OF ANTIBIOTICS, 1995, 48 (11) :1262-1266
[56]   Apicularens A and B, new cytostatic macrolides from Chondromyces species (Myxobacteria):: Production, physico-chemical and biological properties [J].
Kunze, B ;
Jansen, R ;
Sasse, F ;
Höfle, G ;
Reichenbach, H .
JOURNAL OF ANTIBIOTICS, 1998, 51 (12) :1075-1080
[57]   Optimizing the heterologous production of epothilone D in Myxococcus xanthus [J].
Lau, J ;
Frykman, S ;
Regentin, R ;
Ou, S ;
Tsuruta, H ;
Licari, P .
BIOTECHNOLOGY AND BIOENGINEERING, 2002, 78 (03) :280-288
[58]   A novel biosynthetic pathway providing precursors for fatty acid biosynthesis and secondary metabolite formation in myxobacteria [J].
Mahmud, T ;
Bode, HB ;
Silakowski, B ;
Kroppenstedt, RM ;
Xu, MJ ;
Nordhoff, S ;
Höfle, G ;
Müller, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (36) :32768-32774
[59]   SCALING-UP OF PROCESS FOR PRODUCTION OF ANTIBIOTIC OF MYXOCOCCUS-XANTHUS TA [J].
MIZRAHI, A ;
ARNAN, J ;
MILLER, G ;
LIRON, Z ;
MANAI, M ;
BATUS, Y ;
ROSENBERG, E .
JOURNAL OF APPLIED CHEMISTRY AND BIOTECHNOLOGY, 1976, 26 (03) :160-166
[60]   The biosynthetic gene cluster for the microtubule-stabilizing agents epothilones A and B from Sorangium cellulosum So ce90 [J].
Molnár, I ;
Schupp, T ;
Ono, M ;
Zirkle, RE ;
Milnamow, M ;
Nowak-Thompson, B ;
Engel, N ;
Toupet, C ;
Stratmann, A ;
Cyr, DD ;
Gorlach, J ;
Mayo, JM ;
Hu, A ;
Goff, S ;
Schmid, J ;
Ligon, JM .
CHEMISTRY & BIOLOGY, 2000, 7 (02) :97-109